Clinical Trial Update: A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating the efficacy of vonoprazan 20 mg once daily for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• vonoprazan 20 mg (vonoprazan)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Vonoprazan, Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN